drugset / Trial / NCT02824432

Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation

NCT02824432

Phase 4 Completed 37 enrolled Takeda
RandomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to explore the effects of omega-3-acid ethyl esters (TAK-085) on vascular endothelial function when administered for 8 weeks, as measured by FMD, in patients with hyperlipidemia.

Timeline

Start
2016-08-04
Primary completion
2017-08-19
Completion
2017-08-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Lovaza Other / unclassified 2 g Oral
Subject Lovaza Other / unclassified 4 g Oral

Indications